Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro

dc.contributor.author	Jorge Fernández, Monica
dc.date.accessioned	2017-06-07T07:04:30Z
dc.date.available	2017-06-07T07:04:30Z
dc.date.issued	2013
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2282
dc.language.iso	eng
dc.title	Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro
dc.type	Artigo	es
dc.authorsophos	Feliu, J.
dc.authorsophos	Salud, A.
dc.authorsophos	Safont, M. J.
dc.authorsophos	Garcia-Giron, C.
dc.authorsophos	Aparicio, J.
dc.authorsophos	Vera, R.
dc.authorsophos	Serra, O.
dc.authorsophos	Casado, E.
dc.authorsophos	Jorge, M.
dc.authorsophos	Maurel, J.
dc.identifier.isi	326843603435
dc.identifier.sophos	13025
dc.journal.title	EUROPEAN JOURNAL OF CANCER
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Oncoloxía médica
dc.page.initial	S553
dc.page.final	S553
dc.rights.accessRights	openAccess
dc.typesophos	Artículo de Opinión
dc.volume.number	49

Files in this item

Files	Size	Format	View
There are no files associated with this item.